Skip to main content

Want a detailed portfolio tracker?

PRE
NASDAQ
$20.83

Prenetics Global Ltd - Class A (PRE)

Prenetics Global Ltd (PRE) is an innovative health technology company that specializes in advanced genetic and diagnostic testing solutions, offering invaluable health insights to consumers and healthcare professionals alike. With a robust focus on research and development, Prenetics has built a strong international footprint through strategic partnerships and collaborations, enhancing its market visibility. As a frontrunner in personalized medicine, the company is strategically positioned to leverage the growing demand for accessible health data, presenting a compelling investment opportunity within the dynamic healthcare sector.
Website: https://www.prenetics.com
68 analysts
Buy
Target: $34.20 (+64.19%)

Market Cap

$333M

Free Cash Flow Yield

-11.92%

Beta (5Y)

0.04

Price Chart

Valuation
Market Cap$333M
P/S3.01
P/B2.64
Profitability
Total Revenue (TTM)$114M
Gross Profit (TTM)$66M
EBITDA-$52M
Profit Margin-64.3%
Operating Margin-27%
EPS-$4.58
Financial Health
Debt-to-Equity0.4%
Free Cash Flow Yield-11.92%
Growth & Risk
Revenue 5Y CAGR-0.83%
Beta (5Y)0.04
Sharpe Ratio1.47